clinical trial · NCT05152173
Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis
Plantar FibromatosisEN3835Placebo
brief summary
This randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of up to 2 treatments of EN3835 vs placebo in participants with plantar fibromatosis.
started
Nov 29, 2021
primary completion
Jan 10, 2023
completion
Jan 10, 2023
last updated
Mar 27, 2026
official title
Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol